WBR0087: Difference between revisions

Jump to navigation Jump to search
Ochuko Ajari (talk | contribs)
No edit summary
WikiBot (talk | contribs)
m refreshing WBR questions
 
(12 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor={{Ochuko}}
|QuestionAuthor= {{Ochuko}} (Reviewed by Will Gibson, [[user: Jad Al Danaf|Jad Al Danaf]],  {{Rim}}, and Yazan Daaboul)
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Biochemistry, Genetics
|MainCategory=Genetics
|SubCategory=Neurology
|SubCategory=Neurology
|MainCategory=Biochemistry, Genetics
|MainCategory=Genetics
|SubCategory=Neurology
|SubCategory=Neurology
|MainCategory=Biochemistry, Genetics
|MainCategory=Genetics
|SubCategory=Neurology
|SubCategory=Neurology
|MainCategory=Biochemistry, Genetics
|MainCategory=Genetics
|MainCategory=Biochemistry, Genetics
|MainCategory=Genetics
|MainCategory=Genetics
|SubCategory=Neurology
|SubCategory=Neurology
|MainCategory=Biochemistry, Genetics
|MainCategory=Genetics
|SubCategory=Neurology
|SubCategory=Neurology
|MainCategory=Biochemistry, Genetics
|MainCategory=Genetics
|SubCategory=Neurology
|SubCategory=Neurology
|MainCategory=Biochemistry, Genetics
|MainCategory=Genetics
|SubCategory=Neurology
|SubCategory=Neurology
|MainCategory=Biochemistry, Genetics
|MainCategory=Genetics
|MainCategory=Biochemistry, Genetics
|MainCategory=Genetics
|SubCategory=Neurology
|SubCategory=Neurology
|Prompt=A 56-year old man presents to the physicians office with a history of difficulty with swallowing, involuntary jerky movements of the hands, progressive loss of speech and memory. His father died of similar symptoms and his symptoms is said to be worse than his father’s. This condition is an example of which of the following?
|Prompt=A 40-year-old man is brought to his physician's office by his wife for aggressive behavior, involuntary rhythmic jerking movements of the hands, and memory loss. His symptoms have been progressively worsening for the past 6 months. The patient's father died of similar symptoms at the age of 55. The patient does not smoke cigarettes and only drinks alcohol occasionally. He denies use of medications or illicit drugs. The patient's condition is an example of which of the following genetic disorders?
|Explanation=The patient in this vignette has Huntington’s disease.  It is an example of anticipation where the severity of the disease worsens or age of onset of disease is earlier in succeeding generations. Symptoms manifest in affected individuals between the ages of 20 and 50. It is a trinucleotide repeat disorder (CAG)n with the gene located on chromosome 4. Findings include depression, progressive dementia, choreiform movements, caudate atrophy and decreased levels of GABA and Ach in the brain.
|Explanation=[[Huntington’s disease]] (HD) is an autosomal dominant neurodegenerative genetic disease caused by polyglutamine expansion in the coding region of the gene ''IT15'' that codes for the huntingtin (''HTT'') protein. Huntington's disease is characterized by the presence of unstable trinucleotide repeats (CAG) in the ''Huntingtin'' (HTT) gene located on the short arm of chromosome 4 (4p63). The CAG repeat length and paternal transmission are both significantly correlated with the onset of symptoms. HD is thus a classical example of [[anticipation]], defined as the more severe and/or earlier onset of symptoms in successive generations within a pedigree.
 
Most patients with the HD mutation lead a normal life during early adulthood. Symptoms manifest in affected individuals between the ages of 20 and 50. Clinically, Huntington's disease is characterized by the presence of the triad: psychiatric symptoms, motor dysfunction, and cognitive impairment due to [[caudate]] atrophy and decreased levels of both [[GABA]] and [[acetylcholine]] in the brain.
|AnswerA=Loss of heterozygosity
|AnswerA=Loss of heterozygosity
|AnswerAExp=An example loss of heterozygosity is retinoblastoma. If there is an inheritance or development of a mutation in a tumor suppressor gene, the complementary allele must be deleted/mutated before cancer develops.
|AnswerAExp=[[Loss of heterozygosity]] refers to the loss of genetic material constituting a second, usually wild-type, allele. One classical example of loss of heterozygosity occurs in the development of [[retinoblastoma]]. For most tumor suppressor genes, the complementary allele must be deleted/mutated before cancer develops.
|AnswerB=Locus heterogeneity
|AnswerB=Locus heterogeneity
|AnswerBExp=Locus heterogeneity is exhibited by Marfan’s syndrome, MEN 2B and homocystinuria. Mutations at different loci produce the same phenotype.
|AnswerBExp=Locus heterogeneity refers to the phenomenon in which mutations at different loci produce the same phenotype. Locus heterogeneity is exhibited by [[Marfan’s syndrome]], [[MEN 2B]], and [[homocystinuria]].
|AnswerC=Genomic imprinting
|AnswerC=Genomic imprinting
|AnswerCExp=Genomic imprinting is seen in Prader-Willi syndrome and Angelman syndrome where the differences in phenotype depend on the origin of the mutation whether it is paternal or maternal.
|AnswerCExp=[[Genomic imprinting]] is an epigenetic phenomenon by which certain genes can be expressed in a parent-of-origin-specific manner. The expression of one parental allele is often silenced by DNA methylation. Genomic imprinting is seen in [[Prader-Willi syndrome]] and [[Angelman syndrome]], where the differences in phenotype depend on whether the chromosome carrying a deletion is inherited from the father or the mother.
|AnswerD=Anticipation
|AnswerD=Anticipation
|AnswerDExp=Anticipation is exhibited by Huntington disease, where the severity of the disease worsens, or age of onset of disease is earlier in succeeding generations
|AnswerDExp=[[Anticipation]] refers to the phenomenon in which disease severity worsens or the age of onset of symptoms becomes earlier in succeeding generations. The patient in this vignette is exhibiting symptoms of [[Huntington's disease]], a classic syndrome for genetic anticipation.
|AnswerE=Pleitropy
|AnswerE=Pleitropy
|AnswerEExp=Pleitropy is seen in phenylketonuria where one gene has greater than one effect on an individual’s phenotype.
|AnswerEExp=[[Pleiotropy]] occurs when one gene influences multiple, seemingly unrelated phenotypic traits. Pleitropy is observed in [[phenylketonuria]] where a defect in a single gene causes severe cognitive abnormalities as well as separate dermatological abnormalities.
|EducationalObjectives=[[Anticipation]] refers more severe and/or earlier onset of symptoms of a genetic disorder in successive generations within a [[pedigree]]. [[Huntington's disease]], characterized by psychiatric symptoms, motor dysfunction, and cognitive impairment, is a classical example of anticipation.
|References=Langbehn DR, Hayden M, Paulsen JS, et al. CAG-repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(2):397-408.
 
Ranen NG, Stine OC, Abbott MH, et al. Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease. Am J Hum Genet.1995;57(3):593-602.
 
First Aid 2014 page 84
|RightAnswer=D
|RightAnswer=D
|WBRKeyword=Huntington's disease, Huntington disease, Genetics, Inherited, Anticipation, trinucleotide repeat disorders,Inheritance, Neurodegenerative
|Approved=Yes
|Approved=Yes
}}
}}

Latest revision as of 23:17, 27 October 2020

 
Author [[PageAuthor::Ogheneochuko Ajari, MB.BS, MS [1] (Reviewed by Will Gibson, Jad Al Danaf, Rim Halaby, M.D. [2], and Yazan Daaboul)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Genetics
Sub Category SubCategory::Neurology
Prompt [[Prompt::A 40-year-old man is brought to his physician's office by his wife for aggressive behavior, involuntary rhythmic jerking movements of the hands, and memory loss. His symptoms have been progressively worsening for the past 6 months. The patient's father died of similar symptoms at the age of 55. The patient does not smoke cigarettes and only drinks alcohol occasionally. He denies use of medications or illicit drugs. The patient's condition is an example of which of the following genetic disorders?]]
Answer A AnswerA::Loss of heterozygosity
Answer A Explanation [[AnswerAExp::Loss of heterozygosity refers to the loss of genetic material constituting a second, usually wild-type, allele. One classical example of loss of heterozygosity occurs in the development of retinoblastoma. For most tumor suppressor genes, the complementary allele must be deleted/mutated before cancer develops.]]
Answer B AnswerB::Locus heterogeneity
Answer B Explanation [[AnswerBExp::Locus heterogeneity refers to the phenomenon in which mutations at different loci produce the same phenotype. Locus heterogeneity is exhibited by Marfan’s syndrome, MEN 2B, and homocystinuria.]]
Answer C AnswerC::Genomic imprinting
Answer C Explanation [[AnswerCExp::Genomic imprinting is an epigenetic phenomenon by which certain genes can be expressed in a parent-of-origin-specific manner. The expression of one parental allele is often silenced by DNA methylation. Genomic imprinting is seen in Prader-Willi syndrome and Angelman syndrome, where the differences in phenotype depend on whether the chromosome carrying a deletion is inherited from the father or the mother.]]
Answer D AnswerD::Anticipation
Answer D Explanation [[AnswerDExp::Anticipation refers to the phenomenon in which disease severity worsens or the age of onset of symptoms becomes earlier in succeeding generations. The patient in this vignette is exhibiting symptoms of Huntington's disease, a classic syndrome for genetic anticipation.]]
Answer E AnswerE::Pleitropy
Answer E Explanation [[AnswerEExp::Pleiotropy occurs when one gene influences multiple, seemingly unrelated phenotypic traits. Pleitropy is observed in phenylketonuria where a defect in a single gene causes severe cognitive abnormalities as well as separate dermatological abnormalities.]]
Right Answer RightAnswer::D
Explanation [[Explanation::Huntington’s disease (HD) is an autosomal dominant neurodegenerative genetic disease caused by polyglutamine expansion in the coding region of the gene IT15 that codes for the huntingtin (HTT) protein. Huntington's disease is characterized by the presence of unstable trinucleotide repeats (CAG) in the Huntingtin (HTT) gene located on the short arm of chromosome 4 (4p63). The CAG repeat length and paternal transmission are both significantly correlated with the onset of symptoms. HD is thus a classical example of anticipation, defined as the more severe and/or earlier onset of symptoms in successive generations within a pedigree.

Most patients with the HD mutation lead a normal life during early adulthood. Symptoms manifest in affected individuals between the ages of 20 and 50. Clinically, Huntington's disease is characterized by the presence of the triad: psychiatric symptoms, motor dysfunction, and cognitive impairment due to caudate atrophy and decreased levels of both GABA and acetylcholine in the brain.
Educational Objective: Anticipation refers more severe and/or earlier onset of symptoms of a genetic disorder in successive generations within a pedigree. Huntington's disease, characterized by psychiatric symptoms, motor dysfunction, and cognitive impairment, is a classical example of anticipation.
References: Langbehn DR, Hayden M, Paulsen JS, et al. CAG-repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(2):397-408.

Ranen NG, Stine OC, Abbott MH, et al. Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease. Am J Hum Genet.1995;57(3):593-602.

First Aid 2014 page 84]]

Approved Approved::Yes
Keyword WBRKeyword::Huntington's disease, WBRKeyword::Huntington disease, WBRKeyword::Genetics, WBRKeyword::Inherited, WBRKeyword::Anticipation, WBRKeyword::trinucleotide repeat disorders, WBRKeyword::Inheritance, WBRKeyword::Neurodegenerative
Linked Question Linked::
Order in Linked Questions LinkedOrder::